Cargando…

The Characteristic Changes in Hepatitis B Virus X Region for Hepatocellular Carcinoma: A Comprehensive Analysis Based on Global Data

OBJECTIVES: Mutations in hepatitis B virus (HBV) X region (HBx) play important roles in hepatocarcinogenesis while the results remain controversial. We sought to clarify potential hepatocellular carcinoma (HCC)-characteristic mutations in HBx from HBV genotype C-infected patients and the distributio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenwen, Goto, Kaku, Matsubara, Yasuo, Ito, Sayaka, Muroyama, Ryosuke, Li, Qiang, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420286/ https://www.ncbi.nlm.nih.gov/pubmed/25942596 http://dx.doi.org/10.1371/journal.pone.0125555

Ejemplares similares

Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study
por: Goto, Kaku, et al.
Publicado: (2016)

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma
por: Kojima, Ryuta, et al.
Publicado: (2023)

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
por: Goto, Kaku, et al.
Publicado: (2016)

Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
por: Goto, Kaku, et al.
Publicado: (2018)

The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells
por: Kanzaki, Hiroaki, et al.
Publicado: (2022)

Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
por: Arai, Jun, et al.
Publicado: (2020)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer
por: Arai, Jun, et al.
Publicado: (2022)

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
por: Ma, Yaojia, et al.
Publicado: (2022)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
por: Fujisawa, Toshio, et al.
Publicado: (2020)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022)

ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis B
por: Li, Qiang, et al.
Publicado: (2012)

Involvement of the 3’ Untranslated Region in Encapsidation of the Hepatitis C Virus
por: Shi, Guoli, et al.
Publicado: (2016)

The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
por: Flores, Joan Ericka, et al.
Publicado: (2022)

Hepatic encephalopathy due to cardiac cirrhosis
por: Ono, Ryohei, et al.
Publicado: (2023)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression Profiles of Hepatic lncRNAs in the Mouse Model of Alcoholic Liver Disease
por: Dou, Xiaobing, et al.
Publicado: (2021)

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Kusakabe, Yuko, et al.
Publicado: (2021)

Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA
por: Ohno, Motoko, et al.
Publicado: (2014)

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2023)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma
por: Xu, Qiaodong, et al.
Publicado: (2019)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2018)

Hepatitis A in the Eastern Mediterranean Region: a comprehensive review
por: Badur, Selim, et al.
Publicado: (2022)

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
por: Yumita, Sae, et al.
Publicado: (2023)

Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma
por: YANG, SHENG-LI, et al.
Publicado: (2014)

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

A Comprehensive Resource of Interacting Protein Regions for Refining Human Transcription Factor Networks
por: Miyamoto-Sato, Etsuko, et al.
Publicado: (2010)

Methylation status of genes escaping from X-chromosome inactivation in patients with X-chromosome rearrangements
por: Kawashima, Sayaka, et al.
Publicado: (2021)

Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019
por: Zhang, Xingxing, et al.
Publicado: (2021)

Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study
por: Okada, Rei, et al.
Publicado: (2022)

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lmmsrd9prn2kp1d3jlh04ic1e